Oxford Nanopore Technologies Statistics, Revenue Totals and Facts (2021)

Here are a few of the most interesting Oxford Nanopore Technologies statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.

Oxford Nanopore Technologies Facts

  • Website: Official Website
  • Year Founded: 2005
  • Headquarters: Oxford, UK
  • Founder(s): Hagan Bayley, Gordon Sanghera and Spike Willcocks
  • Current Chief Executive: Dr Gordon Sanghera

What is Oxford Nanopore Technologies?

Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. (source)

Oxford Nanopore Technologies Employee Count

Number of Oxford Nanopore Technologies employees:

500 employees

Last updated 3/14/20

Oxford Nanopore Technologies Statistics

Number of countries Oxford Nanopore Technologies sells to:

100 countries

Last updated 3/14/20

Amount of funding Oxford Nanopore Technologies has raised to date:

£480 million

Last updated 1/2/20

Estimated value of Oxford Nanopore Technologies:

£1.5 million

Last updated October 2018

Please note that some of these numbers are easier to find than others. A few of these Oxford Nanopore Technologies stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.